Cutting-Edge Science for Eye Health — Dr. Jeffrey Goldberg

Tim Ferriss talks with Stanford ophthalmologist Dr. Jeffrey Goldberg, recruited via a social post about presbyopia (age-related near-vision decline). They cover the basic anatomy of the eye and the spectrum from sick to normal to 'supra-normal' vision, including frame-rate-reducing goggles that train athletes' reflexes. Goldberg surveys the evidence on supplements (AREDS2, vitamin B3/nicotinamide), red and violet light therapy for mitochondria and myopia, pilocarpine-style pupil-constricting eye drops, dry-eye treatments, and serum tears. He explains glaucoma as the number-one cause of irreversible blindness, eye-pressure variability, cannabis's temporary pressure-lowering effect, and the surprising role of the innate immune system and gut microbiome in neurodegeneration. The big thesis: the long-held belief that lost vision can't be recovered is about to topple, with stem-cell and plasticity-based vision restoration moving into human trials within five years.

• Glaucoma is the number one cause of irreversible blindness in the world, and the long-held rule that lost vision cannot be recovered is about to be overturned.
  00:00:00
• Goldberg predicts vision restoration at a totally unprecedented level, with stem-cell and plasticity science moving quickly into safe human clinical trials over the next few years.
  00:00:32
• Athletes can have supra-normal vision (e.g., 20/12), and frame-rate-reducing goggles that dim a fraction of cone refresh frames can train players to perform better at 100% vision after practicing at 60-90%.
  00:04:41
• There is foundational research showing a correlation between vision loss and cognitive decline, and restoring sight (even via simple cataract surgery) can reverse significant cognitive decline and depression in older adults.
  00:31:46
• In germ-free mice, raising eye pressure does NOT cause optic nerve degeneration; transplanting immune cells from a normal mouse triggers the damage, proving the innate immune system drives glaucoma.
  00:49:59
• Goldberg names vision restoration as the paradigm he expects to be overturned in five years, with the brain (cognition, Alzheimer's, spinal cord) likely to follow the eye.
  01:09:42
• Successful mitochondrial transplants are now being done (e.g., into embryos to prevent inherited mitochondrial disease), raising the prospect of transplanting mitochondria into the retina to stave off glaucoma.
  01:20:03

• Around age 40 the lens stops compressing and reshaping to focus up close, causing presbyopia even when distance vision stays sharp.
  00:03:09
• Cones have a refresh rate of roughly 30 to 60 frames per second, similar to computer screens.
  00:05:15
• FDA-approved eye drops shrink the pupil toward a pinhole, normalizing incoming light and temporarily correcting refractive error without glasses.
  00:08:24
• About one third of the brain inside the skull is dedicated to processing vision, and the retina and optic nerve are developmentally an outgrowth of the brain.
  00:20:16
• A small daily dose of red light, and surprisingly also violet light at the opposite end of the spectrum, can slow myopia progression in teens and younger children.
  00:28:07
• Glaucoma is the most common neurodegenerative disease after Alzheimer's; baseline risk is about 2% but rises to ~20% with a first-degree relative who has it.
  00:42:11
• Cannabis (smoked or eaten) lowers eye pressure, but only while you are high, so Goldberg recommends an eye drop instead of being high 24/7.
  00:44:47
• Preservatives in artificial tear bottles are fine at a drop or two a day but become irritating and inflammatory to the ocular surface at higher frequency, so preservative-free strips are recommended.
  00:59:54
• All sunglasses and even clear prescription glasses block UV light, and car and house windows filter UV, so full-spectrum daylight indoors slows childhood myopia without needing UV.
  01:05:03
• ClinicalTrials.gov lets anyone search by disease for actively recruiting trials, and disease foundations plus Stanford Ophthalmology's site list vision restoration trials.
  01:31:59